CN-122005682-A - Traditional Chinese medicine composition for treating chicken phlegm-heat depressed lung as well as preparation method and application thereof

Abstract

The invention belongs to the technical field of traditional Chinese medicine preparations, and in particular relates to a traditional Chinese medicine composition for treating chicken phlegm-heat depressed lung, and a preparation method and application thereof, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 25-35 parts of wild buckwheat rhizome, 15-25 parts of cordate houttuynia, 10-20 parts of baical skullcap root, 5-15 parts of platycodon root, 5-15 parts of almond, 5-15 parts of snakegourd seed, and 4-8 parts of liquorice. The composition has effects of clearing heat, eliminating phlegm, dispersing lung qi, and relieving cough, and can be used for preparing preparation for treating chicken respiratory system diseases and antiinflammatory preparation. Compared with the existing antibiotics and biological agents, the composition has the advantages of no drug residue, no drug resistance, high safety and suitability for preventing and treating the phlegm-heat lung stagnating syndrome of chickens in a large-scale chicken farm.

Inventors

• Fan Yingsai
• PENG YUFAN
• LIU MINGCHUAN
• GONG XINCHENG
• ZHAO XINGHUA
• JIA QI
• YU MENGYUAN
• SHI YETING
• HE PENGYU
• Xia Xiaoshuo

Assignees

• 河北农业大学

Dates

Publication Date

20260512

Application Date

20260408

Claims (8)

1. 1. The traditional Chinese medicine composition for treating chicken phlegm-heat depressed lung is characterized by being prepared from the following raw materials in parts by weight: 25-35 parts of wild buckwheat rhizome, 15-25 parts of cordate houttuynia, 10-20 parts of baical skullcap root, 5-15 parts of platycodon root, 5-15 parts of almond, 5-15 parts of snakegourd seed, and 4-8 parts of liquorice.
2. 2. The traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 30 parts of wild buckwheat rhizome, 20 parts of cordate houttuynia, 15 parts of baical skullcap root, 10 parts of platycodon root, 10 parts of almond, 10 parts of snakegourd seed and 6 parts of liquoric root.
3. 3. The method for preparing the traditional Chinese medicine composition according to claim 1, which comprises the following steps: weighing the raw materials according to the weight parts, and mixing for standby; adding water into the raw materials for soaking, boiling with strong fire after soaking, decocting with slow fire for 20-30 min, and collecting the liquid medicine to obtain the traditional Chinese medicine composition.
4. 4. The method of claim 3, wherein the amount of water added to the drug substance is 8-12 times the weight of the drug substance.
5. 5. The method of claim 3, wherein the soaking time is 0.5 to 2 hours.
6. 6. The method of claim 3, wherein the slow fire is used for 20 minutes.
7. 7. The use of a traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition is used for any one of the following: 1) Preparing a preparation for treating chicken respiratory diseases; 2) Preparing an anti-inflammatory preparation.
8. 8. The use according to claim 1, wherein the formulation further comprises pharmaceutically acceptable excipients.

Description

Traditional Chinese medicine composition for treating chicken phlegm-heat depressed lung as well as preparation method and application thereof Technical Field The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a traditional Chinese medicine composition for treating chicken phlegm-heat depressed lung as well as a preparation method and application thereof. Background The chicken phlegm-heat stagnating in the lung is a high respiratory tract disease syndrome in large-scale chicken raising, can be caused by single or mixed infection of bacteria, mycoplasma, viruses and the like, and is clinically manifested by dyspnea, open mouth and wheeze, wheezing in the throat, obvious tracheal sound and the like. The sectioning inspection can see that the pulmonary congestion and the edema are caused, and the viscous secretion of the bronchus is blocked, so that the death of the chicken is easily caused by choking if the intervention is not performed in time, and obvious economic loss is caused for the breeding industry. The existing prevention and treatment technology and problems aiming at chicken phlegm-heat stagnating lung are summarized as follows: (1) A non-traditional Chinese medicine prevention and treatment means. The western medicine compound treatment is widely applied to the prevention and treatment of phlegm-heat stagnated lung of chickens by combining antibiotics, and has a certain effect on relieving cough and asthma symptoms of chickens caused by sensitive bacteria. However, the long-term or improper use of antibiotics can cause the problem of bacterial drug resistance, so that the minimum antibacterial concentration of the antibiotics is continuously increased, the prevention and control difficulty is increased, the generation and transmission of drug-resistant bacteria not only weaken the prevention and control efficiency of the breeding industry, but also directly threaten the public health safety of human beings through the diffusion of the environment and food chains, and the treatment difficulty and risk of infectious diseases are increased. Meanwhile, the residues of antibiotics in poultry products are not negligible, and the residual antibiotics enter human bodies through food chains, so that the normal flora balance of the human bodies can be destroyed, the risk of human illness is increased, and the food safety is seriously influenced. Vaccine prevention the vaccine can reduce the incidence of diseases related to phlegm-heat stagnated lung of chickens to a certain extent by stimulating the immune system of chickens to produce antibodies and having certain resistance to specific pathogens. Such as vaccines against pathogens such as infectious bronchitis and mycoplasma gallisepticum. However, the development period of the vaccine is long, and a great deal of time and resources are consumed from pathogen research and vaccine development to clinical trials. And the pathogen is constantly mutated, so that the vaccine is difficult to cover all mutated strains, and the protection effect is limited. In addition, the vaccination needs professional personnel to operate according to strict programs, has high requirements on storage, dilution, dose control, vaccination mode and the like, and increases the culture cost and the management difficulty. (2) The traditional Chinese medicine can prevent and treat the current situation. In the field of prevention and treatment of chicken lung diseases, more traditional Chinese medicine compositions for treating lung heat cough and asthma are available at present. Taking classical Ma xing Shi Gan prescription as an example, the traditional Ma Xing Shi Gan prescription has the effects of clearing heat, ventilating lung, relieving cough and asthma, and has obvious treatment effect on chicken lung heat cough and asthma. However, the treatment effect of the traditional Chinese medicine combination aiming at the syndrome of phlegm-heat stagnating in the lung of chicken needs to be further improved. The syndrome of phlegm-heat stagnating in the lung of chicken is similar to cough and asthma due to lung heat, but has obvious differences. The pattern of phlegm-heat stagnating in the lung emphasizes that the pathogenic phlegm and heat are mutually paced in the lung, and besides cough and dyspnea, there are often symptoms of excessive sticky nose and phlegm, wheezing in the throat, stretching mouth and neck and breathing. When a prescription for treating cough and asthma due to lung heat is used for treating the syndrome of phlegm-heat stagnating in lung, the curative effect is satisfactory. This is because these prescriptions are mainly focused on clearing heat and relieving asthma, and have poor pertinence to the prominent phlegm in the phlegm-heat stagnated lung syndrome, so that the medicines cannot effectively cope with the complex pathological mechanism of the phlegm-heat stagnated lung syndrome, and thu